Literature DB >> 7517207

Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex.

B R Curtis1, J G McFarland, G G Wu, G P Visentin, R H Aster.   

Abstract

Drug-dependent IgG antibodies (DDAb) induced by sulfamethoxazole (SMX) and sulfisoxazole (SIX) were identified by flow cytometry in 15 patients who developed thrombocytopenia while taking one of these medications. Fourteen of the 15 DDAb were specific solely for the glycoprotein (GP)IIb/IIIa complex, and 13 of these reacted wholly or in part with epitopes present only on the intact GPIIb/IIIa heterodimer. None of 12 SMX-induced DDAb cross-reacted with SIX, but one of three SIX-induced antibodies reacted with SMX. Each of 10 SMX-induced DDAb tested reacted with the N1-acetyl metabolite of SMX, but only one reacted fully with the N4-acetyl derivative. Detection of the SMX- and SIX-dependent antibodies was facilitated by using bovine serum albumin (BSA) to achieve suspension of these weakly soluble drugs in an aqueous medium. Our findings indicate that DDAb induced by SMX and SIX, in contrast to those induced by quinidine and quinine, are mainly specific for GPIIb/IIIa and react preferentially with calcium-dependent epitopes present only on the intact GPIIb/IIIa heterodimer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517207

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.

Authors:  Jessica A Reese; Xiaoning Li; Manfred Hauben; Richard H Aster; Daniel W Bougie; Brian R Curtis; James N George; Sara K Vesely
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

Review 2.  Considerations when prescribing trimethoprim-sulfamethoxazole.

Authors:  Joanne M-W Ho; David N Juurlink
Journal:  CMAJ       Date:  2011-10-11       Impact factor: 8.262

3.  Acute thrombocytopenia in patients treated with amiodarone is caused by antibodies specific for platelet membrane glycoproteins.

Authors:  Mervyn A Sahud; Michael Caulfield; Nigel Clarke; Robert Koch; Daniel Bougie; Richard Aster
Journal:  Br J Haematol       Date:  2013-08-19       Impact factor: 6.998

4.  Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH.

Authors:  D M Arnold; B R Curtis; T Bakchoul
Journal:  J Thromb Haemost       Date:  2015-02-17       Impact factor: 5.824

5.  Thrombocytopenia in a nutshell.

Authors:  Roos Achterbergh; Henricus J Vermeer; Brian R Curtis; Leendert Porcelijn; Richard H Aster; Wendy Deenik; Catharine Daemen-Gubbels
Journal:  Lancet       Date:  2012-02-25       Impact factor: 79.321

6.  Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device.

Authors:  Mohamad O Khawandanah; Susan M Weiss; Mohamad A Cherry; Hossein Maymani; George B Selby; Richard H Aster; James N George; Jennifer L Holter Chakrabarty
Journal:  Transfusion       Date:  2014-09-11       Impact factor: 3.157

7.  A 39-year-old female patient with metastatic rectal cancer develops thrombocytopenia.

Authors:  Haifaa Dbouk; Simon Mentha; Deborah Mukherji; Jean Lee; Ali Haydar; Ali Shamseddine; Eileen M O'Reilly; Leonard Saltz; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2014-03

8.  Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities.

Authors:  Mark A Howard; Andrea B Hibbard; Deirdra R Terrell; Patrick J Medina; Sara K Vesely; James N George
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

9.  Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia.

Authors:  Daniel W Bougie; Dhirendra Nayak; Brian Boylan; Peter J Newman; Richard H Aster
Journal:  Blood       Date:  2010-06-29       Impact factor: 22.113

Review 10.  Drug-induced thrombocytopenia.

Authors:  Gian Paolo Visentin; Chao Yan Liu
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.